Last reviewed · How we verify

NCT07260383

Telerehabilitation Support for Home Exercise in Mild AIS

Completed NA Last updated 3 December 2025
What this trial tests

NA trial testing home exercise in Scoliosis Idiopathic in 29 participants. Completed in 13 September 2025.

Timeline
20 June 2023
Primary endpoint
26 April 2025
13 September 2025

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment29
Start date20 June 2023
Primary completion26 April 2025
Estimated completion13 September 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 10 to 18, any sex, with Scoliosis Idiopathic or Telerehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adolescent idiopathic scoliosis (AIS) is a three-dimensional spinal deformity that affects postural alignment, function, and quality of life. Telerehabilitation has emerged as a promising approach to enhance accessibility and continuity of exercise-based treatment in AIS. This study aimed to compare the effects of telerehabilitation-supported home exercise programs with standard home exercises on posture, pain, body image, and quality of life in adolescents with mild AIS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Enhancing Home-Based Exercise Therapy with Telerehabilitation in Mild Adolescent Idiopathic Scoliosis: A Randomized Controlled Trial.
    Takinacı ZD, Çelik M, Yıldız Ş, Talmaç MA, et al · · 2025 · PMID 41516952 · DOI 10.3390/healthcare14010019

Verify or expand the search:

Other trials of home exercise

Trials testing the same drug.

Other recruiting trials for Scoliosis Idiopathic

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07260383.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing